Anil V Parwani
Overview
Explore the profile of Anil V Parwani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
298
Citations
4417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Graf E, Soliman A, Marouf M, Parwani A, Pancholi P
Am J Clin Pathol
. 2025 Feb;
PMID: 39982805
No abstract available.
2.
Zia S, Yildiz-Aktas I, Zia F, Parwani A
Diagn Pathol
. 2025 Feb;
20(1):17.
PMID: 39940046
Digital Pathology or whole slide imaging (WSI) is a diagnostic evaluation technique that produces digital images of high quality from tissue fragments. These images are formed on glass slides and...
3.
Brodsky V, Ullah E, Bychkov A, Song A, Walk E, Louis P, et al.
Arch Pathol Lab Med
. 2025 Jan;
PMID: 39836377
Context.—: Generative artificial intelligence (AI) has emerged as a transformative force in various fields, including anatomic pathology, where it offers the potential to significantly enhance diagnostic accuracy, workflow efficiency, and...
4.
Li A, Hammond S, Crosby D, Li Z, Parwani A
Clin Breast Cancer
. 2024 Nov;
25(1):38-45.
PMID: 39500658
Background: HER2-targeted therapies have significantly improved outcomes for patients with HER2-positive breast cancer (BC), which represents 15% to 20% of all BC cases. HER2 status is assessed via immunohistochemistry (IHC)...
5.
Li Z, Hu Y, Jones D, Zhao W, Tozbikian G, Parwani A
Mod Pathol
. 2024 Nov;
38(1):100637.
PMID: 39490739
Human epidermal growth factor receptor 2 (HER2)-positive breast carcinoma (BC) encompasses a spectrum of molecular subtypes, characterized by varying HER2/CEP17 ratios and HER2 copy numbers, influencing responses to anti-HER2 therapy....
6.
Lobo A, Mishra S, Acosta A, Kaushal S, Akgul M, Williamson S, et al.
Am J Surg Pathol
. 2024 Oct;
49(1):11-19.
PMID: 39449577
Synovial sarcoma (SS) is a rare genitourinary malignancy with a specific SS18::SSX 1/2 gene fusion in majority of the instances. The paratesticular location of this neoplasm is extremely rare and...
7.
Kaushal S, Jain E, Acosta A, Sangoi A, Lobo A, Jha S, et al.
Hum Pathol
. 2024 Sep;
153:105667.
PMID: 39305965
Pure intertubular seminoma (PITS) of the testis is described as the presence of seminoma cells within the interstitium of testis without any evidence of diffuse growth pattern or mass lesion...
8.
Mohanty S, Lobo A, Jha S, Sangoi A, Akgul M, Trpkov K, et al.
Virchows Arch
. 2024 Sep;
485(5):829-840.
PMID: 39287823
Oncocytic renal neoplasms are a major source of diagnostic challenge in genitourinary pathology; however, they are typically nonaggressive in general, raising the question of whether distinguishing different subtypes, including emerging...
9.
Graf E, Soliman A, Marouf M, Parwani A, Pancholi P
Am J Clin Pathol
. 2024 Aug;
163(2):162-168.
PMID: 39136261
Objectives: This review summarizes the current and potential uses of artificial intelligence (AI) in the current state of clinical microbiology with a focus on replacement of labor-intensive tasks. Methods: A...
10.
Lobo A, Collins K, Kaushal S, Acosta A, Akgul M, Adhya A, et al.
Histopathology
. 2024 Jul;
85(5):748-759.
PMID: 39075659
Aims: Urothelial carcinoma (UC) demonstrates significant molecular and histologic heterogeneity. The WHO 2022 classification has hinted at adding molecular signatures to the morphologic diagnosis. As morphology and associated molecular repertoire...